NPD Stock News 2.37 05/15/2014 18:06:42 China Nepstar Chain Drugstore

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
China Nepstar Chain Drugstore Ltd (NPD) 2.37 $NPD

China Nepstar Chain Drugstore to Report First Quarter 2014 Financial Results on May 29, 2014
PR Newswire - Fri May 09, 4:00AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , a leading retail drugstore chain in China based on the number of directly operated stores, announced today that the Company will report its unaudited financial results for the first quarter of 2014 on May 29, 2014 before the market opens.

China Nepstar Chain Drugstore Filed 2013 Annual Report on Form 20-F
PR Newswire - Tue Apr 22, 10:09AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , a leading retail drugstore chain in China based on the number of directly operated stores, today announced the Company filed its annual report on Form 20-F for the year ended December 31, 2013 with the Securities and Exchange Commission on April 22, 2014. The annual report can be accessed on the Company's investor relations website at http://ir.nepstar.cn. The Company will provide a hard copy of the annual report containing its audited financial statements for the year ended December 31, 2013, free of charge, to its shareholders and ADS holders upon request.

Rite Aid Reaches 52-Week High on Q4 Earnings Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 11, 8:00AM CDT
Rite Aid posted better-than-expected fourth-quarter fiscal 2014 results.

China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2013 Financial Results
PR Newswire - Fri Mar 28, 2:00AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2013.

Buy-Rated Dividend Stocks: Top 3 Companies: NPD, BKCC, CLCT
at The Street - Mon Mar 10, 10:30AM CDT
These 3 dividend stocks are rated a Buy by TheStreet

China Nepstar Chain Drugstore to Report Fourth Quarter and Fiscal Year 2013 Financial Results on March 28, 2014
PR Newswire - Fri Mar 07, 6:00AM CST
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , the largest retail drugstore chain in China based on the number of directly operated stores, announced today that the Company will report its unaudited financial results for the fourth quarter and fiscal year 2013 on Friday, March 28, 2014 before the market opens.

3 Buy-Rated Dividend Stocks Taking The Lead: NPD, PZN, AB
at The Street - Thu Feb 27, 10:30AM CST
These 3 dividend stocks are rated a Buy by TheStreet

Rite Aid Q3 Earnings in Line - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 20, 7:50AM CST
Rite Aid posted third-quarter fiscal 2014 earnings of 4 cents per share, which was in line with the Zacks Consensus Estimate.

China Nepstar Chain Drugstore (NPD) Jumps: Stock Rises 7.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Dec 18, 7:21AM CST
China Nepstar Chain Drugstore Ltd. (NPD) was a big mover last session, as the company saw its shares rise by over 7% on the day.

Tomorrow's Ex-Dividends To Watch: NPD, DHG, CII, BKCC, IGT
at The Street - Tue Dec 17, 9:00AM CST
NPD DHG CII BKCC IGT are going ex-dividend tomorrow, Wednesday, Dec. 18, 2013, 5:00 AM ET

China Nepstar Chain Drugstore Ltd's board to pay USD0.32 per ADS annual dividend
M2 - Tue Nov 26, 6:58AM CST
The board of directors of China Nepstar Chain Drugstore Ltd (NYSE:NPD), a retail drugstore chain in China, on Tuesday declared its annual cash dividend of USD0.32 per American Depositary Share (ADS).

China Nepstar Chain Drugstore Announces Annual Dividend
PR Newswire - Tue Nov 26, 1:00AM CST
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , the largest retail drugstore chain in China based on the number of directly operated stores, today announced that the Board of Directors has declared an annual cash dividend of US$0.32 per American Depositary Share (ADS), which represents a total value to shareholders of approximately US$31.59 million. The distribution of the dividend is conditional upon the approval of the relevant PRC government authorities. The annual dividend is payable before or around January 24, 2014 to shareholders of record as of the close of business on December 20, 2013.

China Nepstar Chain Drugstore Reports Third Quarter 2013 Financial Results
PR Newswire - Tue Nov 26, 1:00AM CST
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the third quarter ended September 30, 2013.

Rite Aid Q2 Earnings Beat, Stock Hits 5-Yr High - Analyst Blog
Mark Vickery - Zacks Investment Research - Fri Sep 20, 7:30AM CDT
Driven by higher adjusted EBITDA and lower interest expenses, Rite Aid posted a quarterly profit for the fourth consecutive quarter.

China Nepstar Chain Drugstore swings to loss in Q2 2013
M2 - Fri Aug 30, 8:24AM CDT
China Nepstar Chain Drugstore Ltd (NPD), a retail drugstore chain in China, on Thursday reported a net loss of CNY3.9m, or CNY0.04 per basic and diluted ADS, for the second quarter of 2013, ended 30 June 2013.

China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2013 Financial Results
PR Newswire - Thu Aug 29, 3:00AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the second quarter ended June 30, 2013.

China Nepstar Chain Drugstore Ltd. to Report Second Quarter 2013 Financial Results
PR Newswire - Thu Aug 08, 5:00AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , the largest retail drugstore chain in China based on the number of directly operated stores, announced today that the Company will report its unaudited financial results for the second quarter ended June 30, 2013 on Thursday, August 29, 2013 before the market opens.

Research and Development Forecast of China Pharmaceutical Chain Market Report, 2013-2017
M2 - Fri Jul 26, 8:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/z55jsz/research_and) has announced the addition of the "Research and Development Forecast of China Pharmaceutical Chain Market, 2013-2017" report to their offering. Firstly the report makes the overview of China pharmaceutical circulation industry's development, makes the introduction and analysis of the industry's management system and related policies and further points out the future investment opportunities of China's pharmaceutical circulation field. Secondly it makes the deep analyses of the development status quo, advantages, existing problems and access barriers etc. of the pharmaceutical chain industry as well as the special chapter analysis of China's top 100 pharmaceutical retail enterprises. Lastly it makes the future development forecast of China's pharmaceutical chain, which can provide the decisive reference for the investment in the industry. Influencing by the rapid development of China's pharmaceutical industry and the increasing aging population, the pharmaceutical retail market develops rapidly, chain enterprises continuing the expansion and the number of the pharmacies increasing continuously. By the end of 2012, the sales amount of China's top 100 pharmaceutical retail enterprises reached CNY 87.877 billion, up 17.51% compared to last year, with the share of 39.06% in China's pharmaceutical retail market. The total number of branches of the top 100 enterprises' direct sale-stores was 50,418 in 2012, up 4.96% year on year. In the increasing market competition, the pharmaceutical retail market maintains the rapid development situation. With the promotion of the construction of Two Networks (pharmaceutical supply network and pharmaceutical monitoring network) and the reform of new cooperative medical care system in the rural areas, the rural pharmaceutical market gets the development, becoming the key areas of the future expansion of chain drugstores. With gradual perfect and comprehensive implementation of the new medical care system reform, China's pharmaceutical retail market ushers the wonderful development opportunity, the pharmaceutical chain industry entering the period of the strategic opportunity with brand development prospect. During the 12th-Five-Year period, the proportion of chain drugstores will account for two thirds of the total drugstores and will be equipped comprehensively with licensed pharmacists. Key Topics Covered: 1. Development of China's Pharmaceutical Circulation Industry 2. Overview of China's Pharmaceutical Chain Industry 3. Special Analysis of China's Top 100 Pharmaceutical Retail Enterprises 4. Key Enterprises of China's Pharmaceutical Chain 5. Future Development of China's Pharmaceutical Chain Companies Mentioned - China Nepstar Chain Drugstore Co., Ltd. - Chongqing Peace Pharmacy Chain Co., Ltd. - Chongqing Tongjunge Pharmacy Chain Store Co., Ltd. - Guangdong Dashenlin Chain Drugstore Co., Ltd. - Hubei Tongjitang Pharmacy Co., Ltd. - Liaoning CDFY Pharmacy Chain Co., Ltd. - Sinopharm Holding Guoda Drugstores Co., Ltd. - Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd. For more information visit http://www.researchandmarkets.com/research/z5...search_and

BCOM, BEAT, NPD, EXXI, HF, TA Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Mon Jul 08, 4:56AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of B Communications Ltd (NASDAQ:BCOM), CardioNet Inc (NASDAQ:BEAT), China Nepstar Chain Drugstore Ltd (NYSE:NPD), Energy XXI (Bermuda) Ltd (NASDAQ:EXXI), Hanfeng Evergreen Inc (NYSE:HF), TransAlta Corp (AMEX:TA) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Honda Prelude’s Hybrid Return Tests a Narrow Niche

Updated Category News Views 0

A low-slung coupe showing up in Newfoundland is not exactly a volume-sales thunderclap, and that is precisely why the 2027 Honda Prelude deserves a closer look. Steele Honda in St. John’s is presenting the hybrid two-door as a fresh choice for buyers who want something livelier than the usual practical commuter. For Honda, and for investors watching Honda Motor Co....

Continue Reading
Zoomlion’s Australian Service Push Looks Built to Last

Updated Category News Views 54

Five Australian business centres are one thing; getting a stalled crane or earthmover moving again is the whole ballgame. Zoomlion’s Nov. 4 customer gathering in Sydney matters because Chairman and CEO Zhan Chunxin kept the discussion on the unglamorous stuff: product quality, technical support, parts availability and local training. That is exactly where an equipment...

Continue Reading
Decibel's Export Engine Masks a Domestic Sales Slip

Updated Category News Views 73

Decibel’s overseas business is doing the heavy lifting, and it is not doing it quietly. Third-quarter net revenue reached $35.1 million, up 7% from a year earlier, while international sales jumped 44% to a record $12.1 million. That split matters more than the headline. Canadian adult-use sales fell 6% to $23.0 million, which means the company is proving it can find...

Continue Reading
Hyster-Yale’s $135 Million Convert Carries Real Cost

Updated Category News Views 82

Forklift makers do not usually get to hide a 7.50% borrowing cost behind glossy financing jargon. Hyster-Yale has priced $135 million of convertible senior notes due in 2031, lifting the deal from the originally announced $125 million. There is also an option for initial purchasers to take another $20 million. For NYSE:HY shareholders, this is not a simple debt cleanup....

Continue Reading
Implantica's U.S. Launch Arrives With Cash Still to Burn

Updated Category News Views 77

RefluxStop has finally stepped onto American soil, and that changes the conversation around Implantica in a very real way. FDA Premarket Approval arrived on August 20, then the first U.S. procedures were completed in early November at the University of Southern California. For a small medtech outfit, clearing that regulatory gate and getting actual patients treated are...

Continue Reading
The Estate Bets Over $1 Billion on Luxury Longevity

Updated Category News Views 108

A billion-dollar wellness promise just wandered into the condominium market. The Estate by sbe says its first three branded residential developments carry combined real estate value above $1 billion and encompass more than 500 units. That is not pocket change, and it is certainly not a routine hotel-brand licensing exercise dressed up with scented candles and a cold...

Continue Reading
Envision’s COP31 Pitch Hinges on Grid Execution, Not Targets

Updated Category News Views 69

A 2,500 GW traffic jam is a rotten place to park climate ambition. Envision Energy used COP31 in Antalya to make the more useful point: clean-power targets mean very little if grids cannot connect, balance and dispatch the electricity. Kane Xu’s message was not another round of flag-waving promises. It was an argument that the constraint has shifted from wanting...

Continue Reading
ACOLT Bets on Gold, Craft, and a Sci-Fi Story World

Updated Category News Views 22

A gold pendant moonlighting as a plot device is not the usual luxury pitch, and thank goodness for that. ACOLT, the Denver-based men's fine jewelry house founded by Colton Hindle, plans an international December 2026 launch of its Gold Collection alongside CHRYSON Volume 1: The Arrival, an original science-fiction comic. The actual hand-forged pieces are meant to show up...

Continue Reading
Replit Bets on Trusted Creators to Sell AI Agents at Work

Updated Category News Views 201

Forty-five creators may sound like a marketing footnote, but Replit is aiming at a real enterprise bottleneck: people do not buy grand AI slogans; they buy proof that a messy internal problem can actually get fixed. Its newly launched Replit & Co. program puts business and technology creators in front of that problem, with product access, demonstrations and direct contact...

Continue Reading
FAMID's Six-Month IVDR Win Opens Europe's Market Door

Updated Category News Views 75

A six-month regulatory sprint is the sort of result that makes a crowded diagnostics field pause and squint. DNV has issued an IVDR certificate to FAMID Biomedical Technology for its E7 Oncoprotein Rapid Test Kit, a Class C in vitro diagnostic intended to aid diagnosis of cervical epithelial cell lesions through detection of HPV E7 oncoprotein in cervical cell samples....

Continue Reading

Top 5 Most Recently Viewed Articles

New York Times: Strong Growth Ahead with Innovative Strategies

Updated Category News Views 103

New York Times Positioned for Future Profit Growth Recently, Deutsche Bank has taken a significant step by initiating coverage on shares of the New York Times (NYSE:NYT) with a promising Buy rating and a price target of $65.00. Their analysis highlights the media company's innovative digital-first subscription model and strong fundamentals as major drivers of growth and...

Continue Reading
Maximizing Opportunities in Today's Commercial Insurance Market

Updated Category News Views 151

Understanding the Current U.S. Commercial Insurance Landscape In today’s economic climate, U.S. commercial insurance buyers are navigating one of the most advantageous periods witnessed in recent years. Despite this promising environment, the looming uncertainties affecting the economy pose challenges that require careful consideration from both buyers and insurers...

Continue Reading
Understanding the Market Activity of Dowlais Group Plc Deals

Updated Category News Views 179

Key Information About Dowlais Group Plc This disclosure pertains to an exempt principal trader engaged in client-serving transactions involving Dowlais Group Plc, providing essential insights into the movements and transactions related to its shares. Notable Dealings by the Exempt Principal Trader As highlighted, important dealings regarding the ordinary shares of Dowlais...

Continue Reading
Golden State Dermatology's Smart Expansion into Los Altos

Updated Category News Views 20

Golden State Dermatology Welcomes Todd Anhalt The Bay Area’s dermatology landscape just got an intriguing development. Todd Anhalt, a veteran dermatologist with a track record as long as a roll of duct tape, has teamed up with Golden State Dermatology (GSD). This Los Altos partnership isn't just about slapping a new name on a door—it's a strategic move to bolster...

Continue Reading
Unlocking Tesla's Future: AI, Innovation, and Growth Strategies

Updated Category News Views 117

Tesla got itself into a tight spot back in the day, trading around 40% lower than its peak. Folks were already getting antsy about where the stock was heading—had to keep an eye on those quarterly delivery numbers. The car side of things? Over 80% of projected revenues for FY24 came straight from that segment, so if it tanked, so did the whole show. Tesla's Valuation...

Continue Reading